Recombinant Antibodies for Immunotherapy

Die Leseprobe wird geladen.
eBook
eBook
96,20
96,20
inkl. gesetzl. MwSt.
inkl. gesetzl. MwSt.
Sofort per Download lieferbar
Sofort per Download lieferbar
Sie können dieses eBook verschenken  i

Weitere Formate

gebundene Ausgabe

€ 111,99

Accordion öffnen
  • Recombinant Antibodies for Immunotherapy

    Cambridge

    Versandfertig innerhalb von 3 Wochen

    € 111,99

    Cambridge

eBook

ab € 96,20

Accordion öffnen

Beschreibung

Recombinant Antibodies for Immunotherapy provides a comprehensive overview of the field of monoclonal antibodies (mAbs), a market that has grown tremendously in recent years. Twenty-five articles by experienced and innovative authors cover the isolation of specific human mAbs, humanization, immunogenicity, technologies for improving efficacy, 'arming' mAbs, novel alternative Ab constructs, increasing half-lives, alternative concepts employing non-immunoglobulin scaffolds, novel therapeutic approaches, a market analysis of therapeutic mAbs, and future developments in the field. The concepts and technologies are illustrated by examples of recombinant antibodies being used in the clinic or in development. This book will appeal to both newcomers and experienced scientists in the field, biology and biotechnology students, research and development departments in the pharmaceutical industry, medical researchers, clinicians, and biotechnology investors.

Produktdetails

Format ePUB i
Herausgeber Melvyn Little
Kopierschutz Ja i
Family Sharing Ja i
Text-to-Speech Ja i
Erscheinungsdatum 27.07.2009
Sprache Englisch
EAN 9780511698927
Verlag Cambridge University Press
Dateigröße 6297 KB

Kundenbewertungen

Es wurden noch keine Bewertungen geschrieben.

  • Artikelbild-0